![]() |
市場調査レポート
商品コード
1702492
日本のソフトジェルカプセル市場:材料タイプ別、原料別、用途別、エンドユーザー別、地域別、機会、予測、2019年~2033年Japan Softgel Capsules Market Assessment, By Material Type, By Source, By Application, By End-user, By Region, Opportunities and Forecast, FY2019-FY2033F |
||||||
カスタマイズ可能
|
日本のソフトジェルカプセル市場:材料タイプ別、原料別、用途別、エンドユーザー別、地域別、機会、予測、2019年~2033年 |
出版日: 2025年04月14日
発行: Market Xcel - Markets and Data
ページ情報: 英文 128 Pages
納期: 3~5営業日
|
日本のソフトジェルカプセルの市場規模は、2026年~2033年の予測期間中に7%のCAGRで拡大し、2025年の4億9,072万米ドルから2033年には8億4,314万米ドルに成長すると予測されています。市場の成長を支えているのは、高齢化社会の急速な拡大、慢性疾患の有病率の上昇、ヘルスケア分野への投資の増加です。世界経済フォーラムの推計によると、日本では10人に1人以上が80歳以上です。この成長は、人口の健康と幸福を確保・維持するための様々な医薬品や薬への要求を増大させ、市場の拡大を支えています。
さらに、ソフトジェルカプセルは、生物学的利用能の向上と摂取のしやすさを提供するため、栄養補助食品や医薬品の送達システムとして好まれており、慢性疾患の管理や栄養所要量の維持に理想的です。一方、日本ではヘルスケア・インフラが拡大し、個別化医療に対する認識が高まっていることも市場の成長に寄与しています。
さらに、カラギーナンフリーや植物由来の製剤の製造など、ソフトジェルカプセルの製造における技術の進歩は、自然で持続可能な製品を求める健康志向の消費者の嗜好にさらに応えています。個別化医療に対する意識の高まりと、日本の強固なヘルスケア・インフラは、日本市場の成長を支える他の主な要因です。
当レポートでは、日本のソフトジェルカプセル市場について調査し、市場の概要とともに、材料タイプ別、原料別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Japan softgel capsules market is projected to witness a CAGR of 7% during the forecast period FY2026-FY2033, growing from USD 490.72 million in FY2025 to USD 843.14 million in FY2033. The market's growth is supported by the rapid expansion of the aging population, rising prevalence of chronic diseases, and increasing investments in the healthcare sector. According to the estimates of the World Economic Forum, over one in ten people are 80 or older in Japan. This growth is augmenting the requirement for various pharmaceutical products and medications to ensure and maintain the health and well-being of the population, supporting the market's expansion.
Moreover, softgel capsules are the preferred delivery system for nutritional supplements and medications as they offer enhanced bioavailability and ease of consumption, making them ideal for managing chronic conditions and maintaining nutritional requirements. Meanwhile, the expanding healthcare infrastructure and rising awareness about personalized medicines in Japan also contribute to the market's growth as different pharmaceutical companies are actively investing in research and development activities to introduce innovative formulations that are tailored to the requirements of the patient population.
Additionally, technological advancements in manufacturing softgel capsules, including production of carrageenan-free and plant-based formulations are further catering to the preferences of the health-conscious consumers seeking natural and sustainable products. Growing awareness about personalized medicines coupled with the country's robust healthcare infrastructure are other major factors sustaining the market's growth in Japan.
Aging Population Supports Market Expansion
As individuals age, they often experience difficulties swallowing tablets due to conditions such as dry mouth or reduced swallowing ability. Softgel capsules due to their gelatinous coating are smooth in nature and provide a convenient and easy-to-swallow alternative for the older population. As per the estimates of the National Institute of Population and Social Security Research, approximately 34.8% of the population will be 65 or older by 2040.
Thus, softgel capsules are widely used in the country for delivering medications and nutritional supplements that help in managing chronic conditions. The enhanced bioavailability of softgel capsules ensures effective absorption of active ingredients, critical for elderly patients that may have compromised digestive systems.
Increasing Emphasis on Health and Wellness Boosts Market Demand
The rising emphasis on health and wellness is Japan due to increasing prevalence of various chronic diseases is augmenting the requirement for different pharmaceutical and nutraceutical products. As per the estimates of an article published in the Journal of Cardiology in March 2024, approximately 310,000 people die from cardiovascular diseases in Japan every year.
The country's population is actively seeking dietary supplements and nutraceuticals for maintaining their overall health and wellbeing and preventing chronic diseases. Additionally, compared to other tablets and powders, softgel capsules offer better stability for reactive ingredients. Meanwhile, functional foods and beverages are also gaining traction in the country. Several of such products use softgels for incorporating their active ingredients to enhance efficacy and maintain potency, further supporting the market's expansion.
Gelatin-based Capsules Account for Significant Share of the Market
The popularity of gelatin-based capsules stems from their ability to encapsulate both liquid and semi-liquid formulations while ensuring enhanced bioavailability and stability of active ingredients. The strong gelatin market in Japan supports this trend, with bovine-sourced gelatin being the largest segment due to its perceived benefits like skin rejuvenation and bone strengthening. Additionally, gelatin's compatibility with pharmaceutical and nutraceutical applications makes it a preferred material for softgel manufacturing. Moreover, its affordability compared to non-animal-based alternatives further contributes to the segment's dominance. As demand for softgel capsules continues to increase in the country, gelatin-based capsules are expected to maintain their position in the market.
Nutraceutical Companies Hold Major Market Share
Due to the increasing health consciousness among the general population and rapid expansion of the aging population, the requirement for nutraceuticals is significantly increasing, bolstering the demand for softgel capsules among nutraceutical companies. In order to maintain their competitive edge and expand their presence, these companies are also focusing on launching new products. For instance, in May 2024, Natural Technology Co., Ltd. launched a new product called Eyepa, an all-in-one supplement for targeting various eye problems including eye strain and dry eyes, among others. The product contains ingredients including, astaxanthin, zeaxanthin, vitamins A, C, and E, pentadecyl, raspberry, zinc, bilberry, Megusurino tree extract, and lutein.
Future Market Scenario (FY2026 - FY2033F)
The market is expected to encounter strong expansion opportunities in the coming years due to the rapid expansion of the pharmaceutical and nutraceutical industries, innovations in softgel capsule technologies, growth of the aging population, and novel product launches. Advanced encapsulation technologies are going to provide higher stability, sustained release mechanism, and targeted delivery of the drug.
Additionally, the market's growth is also supported by increasing investments in local manufacturing to reduce dependency on imports and in research and development of functional and plant-based softgel formulations. Moreover, the integration of plant-based softgel technologies is expected to support the market's expansion, allowing leading players of the market to cater to the preferences of the vegetarian population.
Key Players Landscape and Outlook
The key players of the market are actively investing in expansion of their facilities in Japan, providing lucrative growth opportunities for the market. For instance, in May 2023, Catalent, Inc. expanded its facility in Shiga, Japan to include state-of-the-art cryogenic freezers and material transfer equipment designed to maintain the integrity of advanced therapy products by minimizing their time out of a controlled environment. This move is part of the company's strategy to enhance its ability to handle, store, and manage advanced therapies for clinical supply across the country as well as globally.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.